VLP Biotech
Pre-clinicalUsing our proprietary vaccine platform we will engineer custom recombinant proteins to meet your antibody production needs.
Market Cap
Private
Pipeline
—
Patents
—
Publications
—
Private Company
Funding information not available
About
Using our proprietary vaccine platform we will engineer custom recombinant proteins to meet your antibody production needs.
VaccinesInfectious Disease